Publications

Overview publications per theme:

Overview publications per theme:

  • Coveney M, Garcia Gomez P, Van Doorslaer E, Van Ourti T (2020). Thanks goodness for stickiness. Unravelling the evolution of income-related health inequalities before and after the Great recession in Europe. Journal of Health Economics, 70, 102259.
  • Bertens L, Burgos Ochoa L, Van Ourti T, Steegers E, Been J (2020). Persisting inequalities in birth outcomes related to neighbourhood deprivation. Journal of Epidemiology and Community Health, 74, 232-239.
  • O’Donnell O, Van Ourti T. (2020). Dominance analysis, in: Cookson R., Griffin S., Norheim O., Culyer A.J. (eds.), Distributional cost-effectiveness analysis: Quantifying Health Equity Impacts and Trade-Offs, Oxford University Press: 213-236.
  • O’Donnell O, Van Ourti T. (2020) Rank-dependent equity weights, in: Cookson R., Griffin S., Norheim O., Culyer A.J. (eds.), Distributional cost-effectiveness analysis: Quantifying Health Equity Impacts and Trade-Offs, Oxford University Press: 237-252.

  • Bouckaert N, Gielen A, Van Ourti T (2020). It runs in the family – influenza vaccination and spillover effects. Journal of Health Economics, forthcoming.

Overview publications per theme:

S. Rellstab, P.L.H. Bakx, P. Garcia-Gomez & E.K.A. van Doorslaer (2019). The kids are alright - labour market effects of unexpected parental hospitalisations in the Netherlands. Journal of Health Economics, accepted. doi: 10.1016/j.jhealeco.2019.102275

  • J.A.M. Bom, P.L.H. Bakx, F.T. Schut & E.K.A. van Doorslaer (2019). Health effects of caring for and about parents and spouses. Journal of the Economics of Ageing, 14. doi: 10.1016/j.jeoa.2019.100196
  • M. Gheorghe, R.J. Hoefman, M.M. Versteegh & J. van Exel (2019). Estimating Informal Caregiving Time from Patient EQ-5D Data: The Informal CARE Effect (iCARE) Tool. Pharmacoeconomics (Print), 37 (1), 93-103. doi: 10.1007/s40273-018-0706-6
  • C. Brown, J.M. Tilford, N. Payakachat, K. Williams, K.A. Kuhlthau, J.M. Pyne, R.J. Hoefman & W.B.F. Brouwer (2019). Measuring Caregiver Spillover Effects Associated with Autism Spectrum Disorder: A Comparison of the EQ-5D-3L and SF-6D. Pharmacoeconomics (Print), 37 (4), 609-620.
  • P. baji, D. Golicki, V. Prevolnik-Rupel, W.B.F. Brouwer, Z. Zrubka, L. Gulacsi & M. Pentek (2019). The burden of informal caregiving in Hungary, Poland and Slovenia: results from national representative surveys. The European Journal Of Health Economics, 20 (S1), 5-16.
  • R.J. Hoefman, N.J.A. Van Exel & W.B.F. Brouwer (2019). The monetary valuation of informal care: obtaining pure time valuations using a Discrete Choice Experiment. Pharmacoeconomics (Print), 37 (4), 531-540.
  • M.S. Perry-Duxbury, N.J.A. Van Exel, W.B.F. Brouwer, A. Sköldunger, M. Gonçalves‑Pereira, K. Irving, G. Meyer, G. Selbaek, B. Woods, O. Zanetti, F. Verhey, A. Wimo & R.L.H. Handels (2019). A validation study of the ICECAP‑O in informal carers of people with dementia from eight European Countries. Quality of Life Research, 1-15. doi: 10.1007/s11136-019-02317-3
  • L. Ten Hoopen, P.F.A. De Nijs, J. Duvekot, K. Greaves-Lord, M.H.J. Hillegers, W.B.F. Brouwer & L. Hakkaart - van Roijen (2019). Children with an autism spectrum disorder and their caregivers: capturing health-related and care-related quality of life. Journal of Autism and Developmental Disorders, 49 (323), 1-15. doi: 10.1007/s10803-019-04249-w

Overview publications by theme:

  • B. Ravesteijn, J.L.W. van Kippersluis & E.K.A. van Doorslaer (2018). The Wear and Tear on Health: What is the Role of Occupation? Health Economics, 27 (2), e69-e86.
  • M.N. Wagener, L.W.J. van den Dries, N.J.A. van Exel, H.S. Miedema, E.C.M. van Gorp & P.D.D.M. Roelofs (2018). Determinants of Employment in People Living with HIV in the Netherlands. Journal of Occupational Rehabilitation. doi: https://doi.org/10.1007/s10926-016-9692-8
  • K. Verbooy, M.N. Wagener, M. Kaddouri, P.D.D.M. Roelofs, H. Miedema, E. van Gorp, W. Brouwer & J. van Exel (2018). Are people living with HIV less productive at work? Aids Care-Psychological and Socio-Medical Aspects of Aids/Hiv, 30 (10), 1265-1272. doi: 10.1080/09540121.2018.1447076
  • K. Verbooy, M.N. Wagener, M. Kaddouri, P.D.D.M. Roelofs, H. Miedema, E. van Gorp, W. Brouwer & J. van Exel (2018). Are people living with HIV less productive at work? Aids Care-Psychological and Socio-Medical Aspects of Aids/Hiv, 30 (10), 1265-1272. doi: 10.1080/09540121.2018.1447076

  • F.E. van Nooten, J.J. van Busschbach, M. Agthoven, N.J.A. van Exel & W.B.F. Brouwer (2018). What should we know about the person behind a TTO? The European Journal Of Health Economics, 19 (9), 1207-1211. doi: 10.1007/s10198-018-0975-1
  • M. Ruggeri, C. Drago, V. Moramarco, S. Coretti, J. Köppen, K. Islam, J. Gibson, R. Busse, N.J.A. van Exel, M. Sutton, J.E. Askildsen, C.M. Bond & R.F. Elliot (2018). New professional roles and patient satisfaction: Evidence from a European survey along three clinical pathways.Health Policy, 122(10), 1078-1084. doi: 10.1016/j.healthpol.2018.07.020
  • P.H.M. van Baal, M.S. Perry-Duxbury, P.L.H. Bakx, M.M. Versteegh, E.K.A. van Doorslaer & W.B.F. Brouwer (2018). A cost-effectiveness threshold based on the marginal returns of cardiovascular hospital spending.Health Economics, 28 (1), 87-100. doi: 10.1002/hec.3831
  • S. Knies, J.L. Severens & W.B.F. Brouwer (2018). Integrating clinical and economic evidence in clinical guidelines: More needed than ever! Journal of Evaluation in Clinical Practice.
  • W.B.F. Brouwer (2018). The inclusion of spill-over effects in economic evaluations: Not an optional extra.Pharmacoeconomics (Print).
  • M.Q.N. Hackert, N.J.A. Van Exel & W.B.F. Brouwer (2018). Does the ICECAP-O cover the Physical, Mental and Social Functioning of Older People in the UK? Quality of Life Research.
  • L.M. de Vries, P.H.M. van Baal & W.B.F. Brouwer (2018). Future Costs in Cost-Effectiveness Analyses: Past. Present, Future. Pharmacoeconomics (Online). doi: 10.1007/s40273-018-0749-8
  • A.E. Attema, W.B.F. Brouwer & J.L. Pinto-Prades (2018). Peer effects in health valuation: The relation between rating of contemporaries' health and own health. Health and Quality of Life Outcomes, 16 (1):148. doi: 10.1186/s12955-018-0978-8
  • A.E. Attema, W.B.F. Brouwer & K. Claxton (2018). Discounting in economic evaluations. Pharmacoeconomics (Print), 36 (7), 745-758. doi: 10.1007/s40273-018-0672-z
  • A.E. Attema, H.M. Krol, N.J.A. van Exel & W.B.F. Brouwer (2018). New findings from the time trade-off for income approach to elicit willingness to pay for a quality adjusted life year.European Journal of Health Economics (HEPAC), 19 (2), 277-291. doi: https://doi.org/10.1007/s10198-017-0883-9
  • P.H.M. van Baal, A. Morton, D. Meltzer & W.B.F. Brouwer (2018). Future unrelated medical costs need to be considered in cost effectiveness analysis. European Journal of Health Economics (HEPAC). doi: 10.1007/s10198-018-0976-0
  • P.H.M. van Baal, A. Morton & J.L. Severens (2018). Health care input constraints and cost effectiveness analysis decision rules.Social Science & Medicine, 200 (March), 59-64. doi: 10.1016/j.socscimed.2018.01.026.
  • F.C.W. van Krugten, M. Goorden, A.J.L.M. van Balkom, J. Spijker, W.B.F. Brouwer & L. Hakkaart-van Roijen (2018). Indicators to facilitate the early identification of patients with major depressive disorder in need of highly specialized care: A concept mapping study. Depression and Anxiety, 35 (4), 346-352. doi: https://onlinelibrary.wiley.com/doi/abs/10.1002/da.22741
  • J.H. Vermaire & N.J.A. van Exel (2018). Parental attitudes towards oral health and caries-risk in their children. International Journal of Dental Hygiene. doi: https://doi.org/10.1111/idh.12296
  • T. Rouyard, A.E. Attema, R. Baskerville, J. Leal & A. Gray (2018). Risk attitudes of people with ‘manageable’ chronic disease: An analysis under prospect theory. Social Science & Medicine, 214, 144-153. doi: 10.1016/j.socscimed.2018.08.007
  • Lipman, S.A., Brouwer, W.B.F. & Attema, A.E. (2018). A QALY loss is a QALY loss is a QALY loss: a note on independence of loss aversion from health states. European Journal of Health Economics (HEPAC). doi: 10.1007/s10198-018-1008-9
  • W.B.F. Brouwer, P.H.M. van Baal, N.J.A. van Exel & M.M. Versteegh (2018). When is it too expensive? Cost-effectiveness thresholds and health care decision-making. Journal of Health Economics (HEPAC). doi: 10.1007/s10198-018-1000-4
  • M. Gheorghe, R.J. Hoefman, M.M. Versteegh & N.J.A. van Exel (2018). Estimating Informal Caregiving Time from Patient EQ-5D Data: The Informal CARE Effect (iCARE) Tool. Pharmacoeconomics (Print). doi: 10.1007/s40273-018-0706-6
  • T. Rouyard, A.E. Attema, R. Baskerville, J. Leal & A. Gray (2018). Risk attitudes of people with ‘manageable’ chronic disease: An analysis under prospect theory. Social Science & Medicine, 214, 144-153. doi: 10.1016/j.socscimed.2018.08.007
  • Lipman, S.A., Brouwer, W.B.F. & Attema, A.E. (2018). A QALY loss is a QALY loss is a QALY loss: a note on independence of loss aversion from health states. European Journal of Health Economics (HEPAC). doi: 10.1007/s10198-018-1008-9
  • W.B.F. Brouwer, P.H.M. van Baal, N.J.A. van Exel & M.M. Versteegh (2018). When is it too expensive? Cost-effectiveness thresholds and health care decision-making. Journal of Health Economics (HEPAC). doi: 10.1007/s10198-018-1000-4
  • M. Gheorghe, R.J. Hoefman, M.M. Versteegh & N.J.A. van Exel (2018). Estimating Informal Caregiving Time from Patient EQ-5D Data: The Informal CARE Effect (iCARE) Tool. Pharmacoeconomics (Print). doi: 10.1007/s40273-018-0706-6

  • Baltussen, R., Bijlmakers, L., Jansen, M., Project Team, 2018. Draagvlak voor lastige keuzes. Eindrapport van het Burgerforum ‘Keuzes in de zorg’
  • H. Mason, M. Collins, N. McHugh, J. Godwin, N.J.A. van Exel, C. Donaldson & R. Baker (2018). Is "end of life" a special case? Connecting Q with survey methods to measure societal support for views on the value of life-extending treatments. Health Economics. doi: https://doi.org/10.1002/hec.3640
  • N. McHugh, R. Baker, N.J.A. van Exel, H. Mason, J. Godwin, M. Collins & C. Donaldson (2018). Are life-extending treatments for terminal illnesses a special case? Exploring choices and societal viewpoints. Social Science & Medicine, 198, 61-69. doi: https://doi.org/10.1016/j.socscimed.2017.12.019
  • V.T. Reckers, N.J.A. Van Exel & W.B.F. Brouwer (2018). Looking back and moving forward: On the application of proportional shortfall in healthcare priority setting in the Netherlands.Opent extern Health Policy, 122 (6), 621-629. doi: 10.1016/j.healthpol.2018.04.001
  • V.T. Reckers, N.J.A. Van Exel & W.B.F. Brouwer (2018). Who should receive treatment? An empirical enquiry into the relationship between societal views and preferences concerning healthcare priority setting.Opent extern PLoS One (online), 13 (6):e0198761. doi: 10.1371/journal.pone.0198761

Compare @count study programme

  • @title

    • Duration: @duration
Compare study programmes